Tag: Biomarkers
-
Early Alzheimer’s Detection from Short Speech Samples Using Lightweight, Interpretable Linguistic Markers
Introduction Early detection of Alzheimer’s disease (AD) remains a critical frontier in neurology. Researchers are increasingly turning to linguistics and natural language processing to identify subtle changes in speech that precede more obvious cognitive decline. This article reviews how short speech samples can be leveraged to detect AD risk using lightweight, interpretable linguistic markers. The…
-
Early Alzheimer’s Detection from Short Speech Samples Using Lightweight, Interpretable Linguistic Markers
Overview Early detection of Alzheimer’s disease (AD) remains a critical goal for enabling timely interventions, planning, and care. Recent research explores how short, naturalistic speech samples can reveal subtle linguistic and cognitive changes that precede formal diagnosis. By combining lightweight linguistic markers with interpretable models, researchers aim to create practical screening tools that clinicians, caregivers,…
-
Ghebremichael Lab Unveils Framework for Longitudinal Biomarker Evaluation
New framework advances how we study biomarkers over time Researchers at the Ghebremichael Lab, part of the Ragon Institute, have published a pioneering statistical framework in the Journal of Applied Statistics. The framework addresses a long-standing challenge in clinical research: how to accurately evaluate the diagnostic performance of biomarkers when measurements are taken repeatedly over…
-
Ghebremichael Lab Unveils Statistical Framework for Longitudinal Biomarkers in Clinical Studies
Overview: A New Way to Judge Longitudinal Biomarkers Researchers at the Ghebremichael Lab at the Ragon Institute have introduced a powerful statistical framework designed to properly evaluate the diagnostic performance of biomarkers that are measured repeatedly over time in clinical studies. Published in the Journal of Applied Statistics, this work addresses a long-standing challenge: how…
-
Simple blood test maps hidden Alzheimer’s disease changes
New insights from a large community study A recent community-based study has shed new light on how Alzheimer’s disease-related changes occur in the aging brain. The research suggests that genetic risk and brain changes linked to Alzheimer’s can be far more widespread than symptoms alone would imply. In practical terms, this means a simple blood…
-
Simple blood test reveals hidden Alzheimer’s changes across ages
New evidence shows blood tests can map hidden Alzheimer’s changes A landmark community study suggests that brain changes linked to Alzheimer’s disease are far more widespread as people age than the symptoms alone would indicate. The research, which analyzed blood-based markers associated with brain amyloid and tau proteins, points to a future where a simple…
-
Genetic and Inflammatory Predictors of NDLVC Progression
Understanding nondilated left ventricular cardiomyopathy (NDLVC) NDLVC is a heart condition characterized by structural changes in the left ventricle without dilation. It can lead to symptoms ranging from none to heart failure, arrhythmias, or reduced exercise capacity. A recent large multicenter analysis published in the Canadian Journal of Cardiology highlights an important finding: nearly 40%…
-
Peer-Reviewed Studies Validate Linus Health AI as an Early Digital Biomarker for Alzheimer’s Pathology
Groundbreaking Findings Show AI Detects Alzheimer’s Pathology Earlier New peer-reviewed studies confirm that Linus Health’s artificial intelligence (AI) platform can indicate Alzheimer’s disease pathology before noticeable symptoms emerge. The research suggests that this early digital biomarker could empower patients, caregivers, and healthcare teams to take timely actions that may slow disease progression and preserve independence.…
-
Real-Time Lung Cancer Blood Test: Detect and Monitor in Real Time
New Blood Test Offers Real-Time Detection and Monitoring of Lung Cancer A team of researchers in the United Kingdom has unveiled a pioneering blood test that could change how lung cancer is diagnosed and tracked. By analyzing a specific panel of biomarkers in a patient’s blood, the test promises to detect the disease earlier and…
-
Australian Study Reveals Multisystem Abnormalities in ME/CFS Patients
Groundbreaking Multisystem Findings in ME/CFS In a landmark effort to understand myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), researchers in Australia have identified simultaneous abnormalities across several biological systems in people living with the condition. The study, conducted with a multimodal approach and published in a peer‑reviewed journal, strengthens the view that ME/CFS is a complex, multi-systemic…